HSPCs and off-target effects of CRISPR-Cas9
This article describes the characterization of genome integrity in clinically relevant human hematopoietic stem and progenitor cells (HSPCs) following the use of CRISPR-Cas9 MaxCyte®.
Source: news-medical.net